Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon Jun Kim

Showing results (51-60 of 425) with videos related to

Pageof 43
Sort By:
Journal of Medical Virology|February 26, 2015
Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatmentsYuri Cho, Jeong-Hoon Lee, Su Jong Yu, et al.
Clinical and Molecular Hepatology|January 16, 2016
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in KoreaYuri Cho, Eun Ju Cho, Jeong-Hoon Lee, et al.
Anticancer Research|May 6, 2021
Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete ResponseHyo-Cheol Kim, Jin Woo Choi, Myungsu Lee, et al.
International Journal of Epidemiology|May 15, 2007
SPP1 polymorphisms associated with HBV clearance and HCC occurrenceHyoung Doo Shin, Byung Lae Park, Hyun Sub Cheong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept StudyJeong-Hoon Lee, Yun Bin Lee, Eun Ju Cho, et al.
Drug Design, Development and Therapy|April 21, 2020
Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational StudyGyu Chul Oh, Kwon Wook Joo, Myung-A Kim, et al.
Cardiovascular and Interventional Radiology|May 14, 2017
Prophylactic Temporary Occlusion of the Cystic Artery Using a Fibered Detachable Coil During <sup>90</sup>Y RadioembolizationJin Woo Choi, Min Young Yoo, Hyo-Cheol Kim, et al.
BMC Cancer|October 12, 2011
Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluationHyun-Mi Bae, Jeong-Hoon Lee, Jung-Hwan Yoon, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial ChemoembolizationEun Ju Cho, Su Jong Yu, Yun Bin Lee, et al.
Clinical and Molecular Hepatology|September 26, 2017
Current status and strategies for viral hepatitis control in KoreaDong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, et al.
Pageof 43

Showing results (51-60 of 425) with videos related to

Sort By:
Pageof 43
Journal of Medical Virology|February 26, 2015
Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatmentsYuri Cho, Jeong-Hoon Lee, Su Jong Yu, et al.
Clinical and Molecular Hepatology|January 16, 2016
Sofosbuvir-based therapy for patients with chronic hepatitis C: Early experience of its efficacy and safety in KoreaYuri Cho, Eun Ju Cho, Jeong-Hoon Lee, et al.
Anticancer Research|May 6, 2021
Yttrium-90 Radioembolization for Hepatocellular Carcinoma: Virtual Tumor Absorbed Dose as a Predictor of Complete ResponseHyo-Cheol Kim, Jin Woo Choi, Myungsu Lee, et al.
International Journal of Epidemiology|May 15, 2007
SPP1 polymorphisms associated with HBV clearance and HCC occurrenceHyoung Doo Shin, Byung Lae Park, Hyun Sub Cheong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept StudyJeong-Hoon Lee, Yun Bin Lee, Eun Ju Cho, et al.
Drug Design, Development and Therapy|April 21, 2020
Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational StudyGyu Chul Oh, Kwon Wook Joo, Myung-A Kim, et al.
Cardiovascular and Interventional Radiology|May 14, 2017
Prophylactic Temporary Occlusion of the Cystic Artery Using a Fibered Detachable Coil During <sup>90</sup>Y RadioembolizationJin Woo Choi, Min Young Yoo, Hyo-Cheol Kim, et al.
BMC Cancer|October 12, 2011
Protein induced by vitamin K absence or antagonist-II production is a strong predictive marker for extrahepatic metastases in early hepatocellular carcinoma: a prospective evaluationHyun-Mi Bae, Jeong-Hoon Lee, Jung-Hwan Yoon, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Prognostic Values of Inflammation-Based Scores and Fibrosis Markers in Patients with Hepatocellular Carcinoma Treated with Transarterial ChemoembolizationEun Ju Cho, Su Jong Yu, Yun Bin Lee, et al.
Clinical and Molecular Hepatology|September 26, 2017
Current status and strategies for viral hepatitis control in KoreaDong Hyun Sinn, Eun Ju Cho, Ji Hoon Kim, et al.
Pageof 43